Rutgers Cancer Institute Ramps up COVID-19 Hydroxychloroquine & Zithromax Trial: Following Success from France’s Méditerranée Infection

Rutgers Cancer Institute Ramps up COVID-19 Hydroxychloroquine & Zithromax Trial: Following Success from France’s Méditerranée Infection

Rutgers Cancer Institute of New Jersey is participating in a COVID-19 study investigating whether azithromycin (Zithromax) combined with hydroxychloroquine (Plaquenil) is better than hydroxychloroquine alone as a possible treatment for patients diagnosed with...

Pin It on Pinterest